ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies.
Low, J.S., Jerak, J., Tortorici, M.A., McCallum, M., Pinto, D., Cassotta, A., Foglierini, M., Mele, F., Abdelnabi, R., Weynand, B., Noack, J., Montiel-Ruiz, M., Bianchi, S., Benigni, F., Sprugasci, N., Joshi, A., Bowen, J.E., Stewart, C., Rexhepaj, M., Walls, A.C., Jarrossay, D., Morone, D., Paparoditis, P., Garzoni, C., Ferrari, P., Ceschi, A., Neyts, J., Purcell, L.A., Snell, G., Corti, D., Lanzavecchia, A., Veesler, D., Sallusto, F.(2022) Science : eabq2679-eabq2679
- PubMed: 35857703 
- DOI: 10.1126/science.abq2679
- Primary Citation of Related Structures:  
7SKZ, 7SL5, 7U09, 7U0A, 7U0E - PubMed Abstract: 
The coronavirus spike (S) glycoprotein attaches to host receptors and mediates viral fusion. Using a broad screening approach, we isolated from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immune donors seven monoclonal antibodies (mAbs) that bind to all human-infecting coronavirus S proteins ...